Remote nerve injection of mu opioid receptor adeno-associated viral vector increases antinociception of intrathecal morphine

Yanping Gu, Ya Xu, Guang Wen Li, Li-Yen Huang

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

We have shown previously that using recombinant adeno-associated viral vector (rAAV) to up-regulate mu opioid receptors (μORs) in dorsal root ganglia (DRGs) increases the potency of subcutaneous morphine. Here we report an improved method of introducing rAAV-μOR viral vectors into DRGs. Instead of injecting the rAAV-μOR gene directly into DRGs as shown before, the vector was introduced into the sciatic nerve of rats. Changes in μOR expression and antinociceptive effects of intrathecal morphine in rAAV-μOR rats were examined. Immunocytochemical studies showed that the transduced μORs were expressed in all types (ie, small, medium, and large) of DRG neurons. The expression of μORs in DRG neurons, quantified by Western blotting, was increased by 1.7-fold 4 weeks after the sciatic nerve injection. The up-regulation persisted for more than 6 months. The effects of intrathecal morphine on paw withdrawal latencies to heat were studied in rats inflamed with complete Freund's adjuvant. Compared with rats injected with rAAV containing the enhanced green fluorescent protein gene (rAAV-EGFP), the antinociceptive potency of intrathecal morphine in rAAV-μOR rats was significantly increased, and the effective dose (ED50) for morphine was 5.4-fold lower (rAAV-μOR: ED50 = 0.84 μg, confidence interval, 0.70-0.99 μg; rAAV-EGFP: ED50 = 4.50 μg, confidence interval, 3.55-5.86 μg). With minimum tissue damage and a large persistent increase in the opioid potency, remote nerve injection of rAAV-μOR to up-regulate μORs could be a useful therapeutic strategy for the treatment of chronic pain.

Original languageEnglish (US)
Pages (from-to)447-454
Number of pages8
JournalJournal of Pain
Volume6
Issue number7
DOIs
StatePublished - Jul 2005

Fingerprint

mu Opioid Receptor
Opioid Receptors
Morphine
Injections
Spinal Ganglia
Up-Regulation
Sciatic Nerve
Confidence Intervals
Neurons
Freund's Adjuvant
Chronic Pain
Opioid Analgesics
Genes
Hot Temperature
Western Blotting

Keywords

  • Antinociception
  • Dorsal root ganglia
  • Intrathecal morphine
  • Mu opioid receptor
  • Recombinant adeno-associated viral

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology
  • Neurology
  • Nursing(all)

Cite this

Remote nerve injection of mu opioid receptor adeno-associated viral vector increases antinociception of intrathecal morphine. / Gu, Yanping; Xu, Ya; Li, Guang Wen; Huang, Li-Yen.

In: Journal of Pain, Vol. 6, No. 7, 07.2005, p. 447-454.

Research output: Contribution to journalArticle

@article{ee2aae7e5efe4dc3b7698aea3bba3795,
title = "Remote nerve injection of mu opioid receptor adeno-associated viral vector increases antinociception of intrathecal morphine",
abstract = "We have shown previously that using recombinant adeno-associated viral vector (rAAV) to up-regulate mu opioid receptors (μORs) in dorsal root ganglia (DRGs) increases the potency of subcutaneous morphine. Here we report an improved method of introducing rAAV-μOR viral vectors into DRGs. Instead of injecting the rAAV-μOR gene directly into DRGs as shown before, the vector was introduced into the sciatic nerve of rats. Changes in μOR expression and antinociceptive effects of intrathecal morphine in rAAV-μOR rats were examined. Immunocytochemical studies showed that the transduced μORs were expressed in all types (ie, small, medium, and large) of DRG neurons. The expression of μORs in DRG neurons, quantified by Western blotting, was increased by 1.7-fold 4 weeks after the sciatic nerve injection. The up-regulation persisted for more than 6 months. The effects of intrathecal morphine on paw withdrawal latencies to heat were studied in rats inflamed with complete Freund's adjuvant. Compared with rats injected with rAAV containing the enhanced green fluorescent protein gene (rAAV-EGFP), the antinociceptive potency of intrathecal morphine in rAAV-μOR rats was significantly increased, and the effective dose (ED50) for morphine was 5.4-fold lower (rAAV-μOR: ED50 = 0.84 μg, confidence interval, 0.70-0.99 μg; rAAV-EGFP: ED50 = 4.50 μg, confidence interval, 3.55-5.86 μg). With minimum tissue damage and a large persistent increase in the opioid potency, remote nerve injection of rAAV-μOR to up-regulate μORs could be a useful therapeutic strategy for the treatment of chronic pain.",
keywords = "Antinociception, Dorsal root ganglia, Intrathecal morphine, Mu opioid receptor, Recombinant adeno-associated viral",
author = "Yanping Gu and Ya Xu and Li, {Guang Wen} and Li-Yen Huang",
year = "2005",
month = "7",
doi = "10.1016/j.jpain.2005.02.005",
language = "English (US)",
volume = "6",
pages = "447--454",
journal = "Journal of Pain",
issn = "1526-5900",
publisher = "Churchill Livingstone",
number = "7",

}

TY - JOUR

T1 - Remote nerve injection of mu opioid receptor adeno-associated viral vector increases antinociception of intrathecal morphine

AU - Gu, Yanping

AU - Xu, Ya

AU - Li, Guang Wen

AU - Huang, Li-Yen

PY - 2005/7

Y1 - 2005/7

N2 - We have shown previously that using recombinant adeno-associated viral vector (rAAV) to up-regulate mu opioid receptors (μORs) in dorsal root ganglia (DRGs) increases the potency of subcutaneous morphine. Here we report an improved method of introducing rAAV-μOR viral vectors into DRGs. Instead of injecting the rAAV-μOR gene directly into DRGs as shown before, the vector was introduced into the sciatic nerve of rats. Changes in μOR expression and antinociceptive effects of intrathecal morphine in rAAV-μOR rats were examined. Immunocytochemical studies showed that the transduced μORs were expressed in all types (ie, small, medium, and large) of DRG neurons. The expression of μORs in DRG neurons, quantified by Western blotting, was increased by 1.7-fold 4 weeks after the sciatic nerve injection. The up-regulation persisted for more than 6 months. The effects of intrathecal morphine on paw withdrawal latencies to heat were studied in rats inflamed with complete Freund's adjuvant. Compared with rats injected with rAAV containing the enhanced green fluorescent protein gene (rAAV-EGFP), the antinociceptive potency of intrathecal morphine in rAAV-μOR rats was significantly increased, and the effective dose (ED50) for morphine was 5.4-fold lower (rAAV-μOR: ED50 = 0.84 μg, confidence interval, 0.70-0.99 μg; rAAV-EGFP: ED50 = 4.50 μg, confidence interval, 3.55-5.86 μg). With minimum tissue damage and a large persistent increase in the opioid potency, remote nerve injection of rAAV-μOR to up-regulate μORs could be a useful therapeutic strategy for the treatment of chronic pain.

AB - We have shown previously that using recombinant adeno-associated viral vector (rAAV) to up-regulate mu opioid receptors (μORs) in dorsal root ganglia (DRGs) increases the potency of subcutaneous morphine. Here we report an improved method of introducing rAAV-μOR viral vectors into DRGs. Instead of injecting the rAAV-μOR gene directly into DRGs as shown before, the vector was introduced into the sciatic nerve of rats. Changes in μOR expression and antinociceptive effects of intrathecal morphine in rAAV-μOR rats were examined. Immunocytochemical studies showed that the transduced μORs were expressed in all types (ie, small, medium, and large) of DRG neurons. The expression of μORs in DRG neurons, quantified by Western blotting, was increased by 1.7-fold 4 weeks after the sciatic nerve injection. The up-regulation persisted for more than 6 months. The effects of intrathecal morphine on paw withdrawal latencies to heat were studied in rats inflamed with complete Freund's adjuvant. Compared with rats injected with rAAV containing the enhanced green fluorescent protein gene (rAAV-EGFP), the antinociceptive potency of intrathecal morphine in rAAV-μOR rats was significantly increased, and the effective dose (ED50) for morphine was 5.4-fold lower (rAAV-μOR: ED50 = 0.84 μg, confidence interval, 0.70-0.99 μg; rAAV-EGFP: ED50 = 4.50 μg, confidence interval, 3.55-5.86 μg). With minimum tissue damage and a large persistent increase in the opioid potency, remote nerve injection of rAAV-μOR to up-regulate μORs could be a useful therapeutic strategy for the treatment of chronic pain.

KW - Antinociception

KW - Dorsal root ganglia

KW - Intrathecal morphine

KW - Mu opioid receptor

KW - Recombinant adeno-associated viral

UR - http://www.scopus.com/inward/record.url?scp=21544475539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21544475539&partnerID=8YFLogxK

U2 - 10.1016/j.jpain.2005.02.005

DO - 10.1016/j.jpain.2005.02.005

M3 - Article

VL - 6

SP - 447

EP - 454

JO - Journal of Pain

JF - Journal of Pain

SN - 1526-5900

IS - 7

ER -